Saccule-to-Utricle Ratio Inversion May ID Early-Stage Meniere Disease
By Lori Solomon HealthDay Reporter
TUESDAY, Sept. 3, 2024 -- The saccule-to-utricle ratio inversion may serve as an effective imaging marker for diagnosis of early-stage Meniere disease, according to a study published online July 27 in The Laryngoscope.
Wenting Deng, M.D., from Sun Yat-Sen Memorial Hospital at Sun Yat-Sen University in Guangzhou, China, and colleagues compared the saccule-to-utricle ratio inversion in patients with early-stage (56 patients) versus late-stage (70 patients) Meniere disease based on magnetic resonance imaging.
The researchers found that 46.43 percent of the early-stage group showed an enlarged saccule that was larger than the utricle, with saccule-to-utricle ratio inversion. In the late-stage Meniere disease group, only four individuals (5.71 percent) showed saccule-to-utricle ratio inversion. Within the early-stage Meniere disease subgroup, those with a disease duration of no more than six months had a higher proportion of saccule-to-utricle ratio inversion than the subgroup with a disease duration of more than six months (70 versus 33.33 percent).
"Saccule-to-utricle ratio inversion may serve as an effective imaging marker for diagnosis of early-stage Meniere disease," the authors write. "Our finding suggests that endolymphatic hydrops in Meniere disease may primarily originate from the saccule."
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted September 2024
Read this next
Declining Childhood Vaccination May Increase Risk for Vaccine-Preventable Infections
WEDNESDAY, April 30, 2025 -- Declining childhood vaccination rates may increase outbreaks of eliminated vaccine-preventable infections within the United States, leading to a...
AACR: Incidence-Based Mortality Dropping for Young Women With Breast Cancer
TUESDAY, April 29, 2025 -- Incidence-based mortality (IBM) declined from 2010 to 2020 among women aged 20 to 49 years diagnosed with breast cancer, according to a study presented...
AACR: Nonsurgical Treatment Feasible for Mismatch Repair-Deficient Tumors
TUESDAY, April 29, 2025 -- A neoadjuvant programmed cell death 1 (PD-1) blockade enables nonoperative management among patients with early-stage mismatch repair-deficient (dMMR)...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.